@article{baldimmunecell,
  added-at = {2014-03-11T11:11:10.000+0100},
  author = {Bald, T and Landsberg, J and Lopez-Ramos, D and Renn, M and Glodde, N and Jansen, P and Gaffal, E and Steitz, J and Tolba, R and Kalinke, U and Limmer, A and Jonsson, G and Holzel, M and Tuting, T},
  biburl = {https://www.bibsonomy.org/bibtex/21842bc5290d3e6417e7b14bbdae6c14b/kalinke},
  editor = {Discov, Cancer},
  interhash = {7e28385eaaae65a508c6e8bbbfcbdaff},
  intrahash = {1842bc5290d3e6417e7b14bbdae6c14b},
  journal = {Cancer Discov},
  keywords = {kalinke},
  number = 6,
  pages = {674-687},
  pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/24589924},
  timestamp = {2014-06-24T09:27:43.000+0200},
  title = {Immune-cell poor melanomas benefit from PD-1 blockade after targeted type I IFN activation},
  volume = 4,
  year = 2014
}